Clinical Trial Update: Biomarkers for Clinical Hypoxia Evaluation in Cervical Cancer

View source ↗

Summary

A University of Manchester-sponsored clinical trial is evaluating biomarkers to assess tumor hypoxia in cervical cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: University of Manchester | Conditions: Cervical Cancer | Status: RECRUITING